{
  "meta": {
    "title": "Neet_Pg_2025",
    "url": "https://brainandscalpel.vercel.app/neet-pg-2025-296cd9fb.html",
    "scrapedAt": "2025-11-30T07:35:01.343Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Conn's disease</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with complaints of salt craving, generalized hyperpigmentation, and laboratory findings of hyperkalemia and metabolic acidosis. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1325328",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325328,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Addison's disease, or primary adrenal insufficiency, causes a deficiency of both glucocorticoids and mineralocorticoids</strong>. This leads to <strong>salt wasting, hyperkalemia</strong> (due to decreased aldosterone), <strong>metabolic acidosis</strong>, and characteristic <strong>skin/mucosal hyperpigmentation</strong> (due to elevated ACTH).</p>\r\n<p><strong>Addison's Disease</strong></p>\r\n<p>Primary adrenal insufficiency (Addison's disease) results in a <strong>deficiency of both glucocorticoids and mineralocorticoids.</strong></p>\r\n<ul>\r\n<li>In Addison's disease, the <strong>destruction of the adrenal cortex </strong>results in electrolyte disturbances-hyponatremia, hyperkalemia, and metabolic acidosis.</li>\r\n<li><strong>Aldosterone deficiency</strong> &rarr; increased Na<sup>+</sup> and water loss, leading to <strong>hypovolemia</strong>, <strong>hypotension</strong>, and <strong>shock.</strong></li>\r\n<li><strong>Cortisol deficiency</strong> &rarr; <strong>decreased gluconeogenesis, hypoglycemia</strong>, and decreased protein/lipid metabolism.</li>\r\n<li>Features of glucocorticoid deficiency include fatigue, weight loss, and poor stress tolerance.</li>\r\n<li><strong>Salt craving </strong>is also a classic symptom due to the body's attempt to <strong>compensate for sodium loss</strong></li>\r\n<li><strong>Hyperpigmentation</strong> may also occur due to<strong> increased ACTH secretion</strong> in primary adrenal insufficiency.</li>\r\n</ul>\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>Conn's disease (Option B): </strong>Causes sodium retention and hypokalemia, not hyperkalemia or hyperpigmentation.</p>\r\n<p><strong>Pheochromocytoma (Option C): </strong>Presents with episodic hypertension, palpitations, and headaches, not salt wasting or skin pigmentation.</p>\r\n<p><strong>Cushing's syndrome (Option D): </strong>Involves glucocorticoid excess with features like hypertension and striae, but does not cause hyperkalemia or pigmentation seen in Addison's disease.</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">High PEEP and high tidal volume</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Low PEEP and low tidal volume</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Low PEEP and high tidal volume</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">High PEEP and low tidal volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A critically ill patient with COVID-19 is admitted to the ICU and requires mechanical ventilation. The patient's PaO<sub>2</sub>/FiO<sub>2</sub> ratio is 100, consistent with severe Acute Respiratory Distress Syndrome. Which of the following ventilatory strategies is most appropriate for managing this patient?</span></p>",
      "unique_key": "DT1325330",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325330,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>For severe ARDS (PaO<sub>2</sub>/FiO<sub>2</sub> &le;100), lung-protective ventilation with low tidal volume (6ml/kg ideal body weight) and high PEEP is recommended.</p>\r\n<ul>\r\n<li>By increasing lung volume and improving alveolar recruitment, PEEP reduces the transpulmonary pressure required to inflate the lungs, hence reducing the work of breathing.</li>\r\n<li>High PEEP helps prevent alveolar collapse and improves oxygenation, while low tidal volume minimizes ventilator-induced lung injury by reducing volutrauma and barotrauma.</li>\r\n<li><strong>PEEP increases FRC </strong>and<strong> reduces the work of breathing.</strong></li>\r\n<li>This approach improves outcomes in patients with severe hypoxemia and is endorsed by current ARDS and COVID-19 critical care guidelines.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>High PEEP and high tidal volume (Option A): </strong>Increases risk of ventilator-induced lung injury due to overdistension (volutrauma).</p>\r\n<p><strong>Low PEEP and low tidal volume (Option B): </strong>May lead to atelectasis and poor oxygenation in severe ARDS.</p>\r\n<p><strong>Low PEEP and high tidal volume (Option C): </strong>Fails to prevent alveolar collapse and increases risk of lung injury.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250922c62a8360-0f6d-4494-9b7b-8104e05c7c2f.png\">",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased IGF-1 levels</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased IGF-1 levels</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Suppressed GH on administration of glucose</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-suppressed GH on administration of glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old boy presents with progressive enlargement of hands and feet, coarse facial features, prominent enlarged jaw, and frontal bossing. On examination, he is noted to have bitemporal hemianopia. Which of the following is the most definitive test to confirm the diagnosis?</span></p>",
      "unique_key": "DT1325332",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325332,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The clinical scenario points towards Acromegaly, characterized by progressive enlargement of hands and feet, coarse facial features, prominent jaw, frontal bossing, and bitemporal hemianopia due to pituitary adenoma. The definitive test for acromegaly/gigantism is failure of growth hormone (GH) suppression after an oral glucose tolerance test (OGTT). Normally, glucose ingestion suppresses GH, but in acromegaly due to a pituitary adenoma, GH levels remain elevated after the glucose load.</p>\r\n<ul>\r\n<li>Acromegaly results from <strong>hypersecretion of growth hormone</strong> either due to a somatotrope adenoma or extra-pituitary lesions.</li>\r\n<li>More common in males.</li>\r\n<li>Both growth hormone and IGF-1 levels are increased.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250910ff171a61-b45b-47b4-ab69-283566e48f89.png\">\r\n<p><strong>Investigations: </strong></p>\r\n<ul>\r\n<li><strong>Screening test: Serum IDF-1 level. </strong><br /> Elevated GH levels increase IGF-1 blood levels, and <strong>elevated IGF-1 levels almost always indicate acromegaly. (Options A &amp; B ruled out) </strong></li>\r\n<li>GH has a pulsatile release, so a random assessment would not be helpful. Because IGF-1 levels are much more stable for the day, they are often a more practical and reliable measure than GH levels.</li>\r\n<li>The <strong>oral glucose tolerance test is the confirmatory test for acromegaly.</strong> Ingestion of <strong>75 g of glucos</strong>e lowers blood <strong>GH levels by less than 0.4 ng/ml in healthy people. </strong>In patients with acromegaly, this reduction does not occur. <strong>(Option C ruled out)</strong></li>\r\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 69-year-old man presents with severe dyspnea and increasing amounts of clear sputum. ABG reveals pH 7.2, PCO<sub>2</sub> 66 mmHg, PaO<sub>2</sub> 44 mmHg, and bicarbonate 26 mEq/L. His SpO<sub>2</sub> is 77%. Which of the following is the underlying abnormality?</span></p>",
      "unique_key": "DT1325335",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This patient's ABG shows a low pH (acidemia), elevated PCO<sub>2</sub> (hypercapnia), and a slightly increased bicarbonate (renal compensation), which is consistent with respiratory acidosis.</li>\r\n<li>Low pH, high pCO<sub>2</sub>, and HCO3 indicate that the primary acid-base disorder is acute respiratory acidosis.</li>\r\n<li>The elevated PCO<sub>2</sub> indicates hypoventilation or respiratory failure, while low PaO<sub>2</sub> and SpO<sub>2</sub> demonstrate hypoxemia. The clinical scenario suggests a likely acute exacerbation of a chronic pulmonary disease (e.g., COPD).</li>\r\n</ul>\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>Metabolic acidosis (Option A): </strong>Would be characterized by low pH and low bicarbonate, not high PCO<sub>2</sub>.</p>\r\n<p><strong>Metabolic alkalosis (Option B): </strong>Would show high pH and high bicarbonate.</p>\r\n<p><strong>Respiratory alkalosis (Option D): </strong>Would show high pH with low PCO<sub>2</sub>.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Add oral corticosteroids</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch to an inhaled corticosteroid plus a long-acting &beta;2-agonist</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase frequency of salbutamol</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Add montelukast at night</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An asthmatic patient on salbutamol and ipratropium continues to have nocturnal exacerbations. Which of the following is the next best step?</span></p>",
      "unique_key": "DT1325340",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325340,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>For a patient with uncontrolled asthma despite use of a short-acting beta agonist (salbutamol) and an anticholinergic (ipratropium), the next recommended step is to add an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). This combination addresses airway inflammation (ICS) and provides prolonged bronchodilation (LABA), improving symptom control and reducing nocturnal exacerbations.</p>\r\n<p><strong>Bronchial asthma</strong> management depends on the severity and frequency of symptoms, as well as objective measures of lung function, such as <strong>forced expiratory volume in 1 second (FEV<sub>1</sub>)</strong>.</p>\r\n<ul>\r\n<li>Patients with <strong>intermittent asthma</strong>, who experience symptoms <strong>less than twice a week</strong> and have <strong>normal FEV<sub>1</sub> (&gt;80%)</strong>, usually require only <strong>as-needed inhaled &beta;<sub>2</sub>-agonists</strong> (e.g., albuterol).</li>\r\n<li>However, if:\r\n<ul>\r\n<li>Symptoms occur <strong>more than twice per week</strong>,</li>\r\n<li><strong>Nocturnal symptoms</strong> are present <strong>more than twice a month</strong>, or</li>\r\n<li><strong>FEV<sub>1</sub> &lt; 80% of predicted</strong>, Then, <strong>additional maintenance therapy</strong> is warranted.</li>\r\n</ul>\r\n</li>\r\n<li>The <strong>first-line controller medication</strong> is a <strong>low-dose inhaled corticosteroid (ICS)</strong>. Alternatives include <strong>leukotriene receptor antagonists (LTRAs)</strong> or <strong>mast cell stabilizers</strong> like <strong>cromolyn</strong>.</li>\r\n<li><strong>Theophylline</strong> is now rarely used due to its narrow therapeutic window and side effect profile and is typically reserved for cases unresponsive to standard therapies.</li>\r\n</ul>\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>Add oral corticosteroids (Option A):</strong> Reserved for severe exacerbations and not for routine long-term control due to side effects.</p>\r\n<p><strong>Increase frequency of salbutamol (Option C): </strong>Can cause side effects and does not address the underlying inflammation.</p>\r\n<p><strong>Add montelukast (Option D):</strong> Used as an add-on in mild-to-moderate asthma, but evidence is stronger for ICS+LABA at this stage.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethambutol</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old boy was diagnosed with meningococcal meningitis. What is the drug of choice (DOC) for prophylaxis to be given to his contacts?</span></p>",
      "unique_key": "DT1325341",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325341,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Rifampicin is the drug of choice for chemoprophylaxis of close contacts of a patient with meningococcal meningitis.</p>\r\n<ul>\r\n<li>Meningococcal meningitis caused by Neisseria meningitidis is highly contagious and spreads through respiratory droplets.</li>\r\n<li>Close contacts-such as roommates, family members, or anyone with prolonged exposure-are at high risk of acquiring the infection.</li>\r\n<li>Chemoprophylaxis is essential to prevent secondary cases.</li>\r\n<li>It is the drug of choice for adults unless contraindicated (e.g., pregnancy, resistance concerns). It effectively eliminates Neisseria meningitidis from the nasopharynx, thereby reducing secondary cases.</li>\r\n<li>Alternatives (such as ciprofloxacin or ceftriaxone) can be used in special situations, but rifampicin remains the standard recommendation in most guidelines.</li>\r\n<li>Rifampicin 600 mg twice daily for 2 days in adults is the standard regimen</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Ethambutol (Option B): </strong>Used for tuberculosis, not effective against Neisseria meningitidis.</p>\r\n<p><strong>Doxycycline (Option C): </strong>Used for a variety of infections, but not recommended for meningococcal prophylaxis.</p>\r\n<p><strong>Amoxicillin (Option D):</strong> Not suitable for meningococcal chemoprophylaxis.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Gout</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudogout</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Amyloidosis</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with pain and swelling of the knee joint. Synovial fluid aspirate shows rhomboid-shaped crystals that are positively birefringent under polarized light microscopy. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1325342",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This is a case of <strong>pseudogout (Calcium Pyrophosphate Deposition Disease-CPPD)</strong> characterized by acute monoarticular arthritis and synovial fluid analysis showing rhomboid-shaped crystals that are positively birefringent under polarized light.</p>\r\n<p><strong>Key diagnostic clues:</strong></p>\r\n<ul>\r\n<li>Joint: Most commonly involves the knee.</li>\r\n<li>Synovial fluid crystals:\r\n<ul>\r\n<li>Positively birefringent under polarized light.</li>\r\n<li>Shape: Rhomboid or rod-shaped crystals (not needle-shaped).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Contrast with Gout:</strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025091090e7ac21-9646-4fae-aa69-4879bd5dfbb0.png\">\r\n<p><strong>Factors and Conditions Associated with Calcium Pyrophosphate Crystal Deposition Disease</strong></p>\r\n<ul>\r\n<li>Aging</li>\r\n<li>Osteoarthritis</li>\r\n<li>Postmeniscectomy or joint trauma</li>\r\n<li>Familial-genetic</li>\r\n<li>Endocrine-metabolic conditions:\r\n<ul>\r\n<li>Primary hyperparathyroidism</li>\r\n<li>Hemochromatosis</li>\r\n<li>Hypophosphatasia</li>\r\n<li>Hypomagnesemia\r\n<ul>\r\n<li>Certain drugs: thiazides and loop diuretics, potentially proton pump inhibitors</li>\r\n<li>Malabsorption</li>\r\n<li>Gitelman's syndrome</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li>Gout</li>\r\n<li>X-linked hypophosphatemic rickets</li>\r\n<li>Familial hypocalciuric hypercalcemia</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Gout (Option A):</strong> Synovial fluid contains <strong>needle-shaped, negatively birefringent monosodium urate crystals</strong>. Commonly involves the <strong>1st MTP joint (podagra)</strong>. Unlike pseudogout, gout crystals are <strong>yellow when parallel</strong> to polarized light and <strong>require urate-lowering therapy</strong>.</p>\r\n<p><strong>Amyloidosis (Option C):</strong> Joint involvement is usually <strong>chronic and polyarticular</strong>. Synovial fluid may show <strong>elevated protein or amyloid deposits</strong>, but <strong>no crystals</strong> are present.</p>\r\n<p><strong>Rheumatoid arthritis (Option D):</strong> Presents as <strong>chronic, symmetric polyarthritis</strong>, often with <strong>morning stiffness</strong>. Synovial fluid is <strong>inflammatory</strong>, but <strong>no rhomboid or positively birefringent crystals</strong> are seen. Serology (RF, anti-CCP) and radiographs help differentiate from crystal arthropathies.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastric antral vascular ectasia</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcinosis cutis</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Interstitial lung disease</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Raynaud's phenomenon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with progressive skin thickening. Laboratory evaluation reveals ANA positivity along with anti-Scl-70 antibodies. Which clinical manifestation is most strongly associated with this antibody?</span></p>",
      "unique_key": "DT1325343",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325343,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Anti-Scl-70 (anti-topoisomerase I) antibodies are highly specific for systemic sclerosis (scleroderma), especially the diffuse cutaneous form. Their presence is strongly associated with an increased risk for developing interstitial lung disease (ILD), which is a leading cause of morbidity and mortality in these patients.</p>\r\n<p><strong>Antibody Association in Systemic Sclerosis</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202509105fc36c83-743a-44f8-81d0-d6030d1a4e69.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Gastric antral vascular ectasia (Option A):</strong> More strongly associated with <strong>anti-RNA polymerase III antibodies</strong>, not anti-Scl-70.</p>\r\n<p><strong>Calcinosis cutis (Option B):</strong> Seen in systemic sclerosis, especially <strong>CREST syndrome</strong>, but <strong>not specifically linked to anti-Scl-70 antibodies</strong>.</p>\r\n<p><strong>Raynaud's phenomenon (Option D):</strong> Common in scleroderma, but not specifically associated with anti-Scl-70 antibody.</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume overload</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Right ventricular failure</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary vein obstruction</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein-losing enteropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with frothy sputum, hemoptysis, paroxysmal nocturnal dyspnea, and dyspnea on exertion. Lung biopsy reveals hemosiderin-laden macrophages. Which of the following conditions is least likely to be associated with this finding?</span></p>",
      "unique_key": "DT1325344",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Hemosiderin-laden macrophages (\"heart failure cells\") in the lungs result from chronic pulmonary congestion, most often due to increased pressure on the pulmonary venous side-commonly seen with left-sided heart failure, pulmonary vein obstruction, or volume overload. Right ventricular failure generally causes systemic venous congestion (e.g., peripheral edema, ascites) and is not a typical cause of pulmonary congestion or hemosiderin-laden macrophages in the lungs.</p>\r\n<p>Hemosiderin-laden macrophages, known as heart failure cells, are characteristic of long-standing pulmonary venous congestion.</p>\r\n<ul>\r\n<li>In <strong>chronic pulmonary congestion</strong>, persistent high pressure in the pulmonary veins causes red cell extravasation into the alveoli.</li>\r\n<li>Alveolar <strong>macrophages phagocytose RBCs</strong>, break down haemoglobin, and store iron as <strong>hemosiderin</strong>, leading to the formation of <strong>heart failure cells</strong>.</li>\r\n<li>These cells are typically found in <strong>lung biopsy specimens</strong> from patients with <strong>left-sided heart failure</strong>.</li>\r\n<li>The interalveolar septa also become <strong>thickened and fibrotic</strong> over time.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Volume overload (Option A):</strong> Can increase pulmonary capillary pressure, resulting in pulmonary congestion and hemosiderin-laden macrophages.</p>\r\n<p><strong>Pulmonary vein obstruction (Option C): </strong>Causes increased back pressure in the pulmonary circulation, leading to this finding.</p>\r\n<p><strong>Protein-losing enteropathy (Option D): </strong>Primarily affects protein absorption but may result from chronic right heart failure; however, it is less directly related than RV failure.</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with anion gap of 30</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with anion gap of 20</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis with anion gap of 30</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis with anion gap of 20</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man presents to the emergency department with altered sensorium, hypotension, and shortness of breath. His arterial blood gas reveals a pH of 7.2, PaCO<sub>2</sub> of 44 mmHg, PaO<sub>2</sub> of 54 mmHg, HCO<sub>3</sub><sup>-</sup> of 16 mEq/L, and a base excess of -12. Serum electrolytes show sodium 130 mEq/L and chloride 84 mEq/L. Based on these findings, what is the most likely acid-base disturbance?</span></p>",
      "unique_key": "DT1325345",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325345,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient has <strong>acidemia (pH 7.2)</strong>, <strong>low bicarbonate (HCO<sub>3</sub><sup>-</sup> = 16)</strong>, and <strong>PaCO<sub>2</sub> near normal (44 mmHg)</strong>. This indicates a <strong>primary metabolic acidosis</strong> without adequate respiratory compensation.</p>\r\n<p><strong>Anion gap calculation:</strong></p>\r\n<p>Anion gap = Na<sup>+</sup>-(Cl<sup>-</sup>+HCO<sub>3</sub><sup>-</sup>) = 130-(84+16) = 130-100 = 30</p>\r\n<p>This represents a <strong>high-anion-gap metabolic acidosis</strong>, most likely due to <strong>lactic acidosis from tissue hypoperfusion</strong> in the context of hypotension and shock. <strong>(Options B, C &amp; D ruled out)</strong></p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">This patient has an increased risk of stroke</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">\"a\" wave is absent on JVP</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">This patient has features of right heart failure</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Pre-systolic accentuation of the mid-diastolic murmur is a hallmark feature</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with a 6-month history of paroxysmal nocturnal dyspnea, palpitations, and breathlessness. On examination, blood pressure and oxygen saturation are normal, jugular venous pressure is elevated, the pulse is irregular, and tender hepatomegaly is present. Cardiac examination reveals a heaving apex and a mid-diastolic murmur at the apex. She has a past history of acute rheumatic fever. Which of the following statements regarding this patient is false?</span></p>",
      "unique_key": "DT1325346",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325346,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient likely has rheumatic mitral stenosis with atrial fibrillation (AF)-suggested by paroxysmal nocturnal dyspnea, irregularly irregular pulse, elevated JVP with absent \"a\" wave, and a mid-diastolic murmur. Pre-systolic accentuation of the mid-diastolic murmur is typically heard only when sinus rhythm is present, due to atrial contraction. In atrial fibrillation, the \"pre-systolic accentuation\" is absent because there is no organized atrial kick.</p>\r\n<ul>\r\n<li><strong>Mitral stenosis (MS)</strong>, most commonly caused by <strong>rheumatic fever</strong>, is characterized by obstruction to <strong>left ventricular inflow</strong>, leading to <strong>elevated left atrial pressure</strong>, <strong>pulmonary congestion</strong>, and eventually <strong>pulmonary hypertension and right heart failure</strong>.</li>\r\n<li>A <strong>key auscultatory feature</strong> of MS is the <strong>opening snap</strong>, a high-frequency sound occurring shortly after the second heart sound (S2), due to the sudden tensing of the stenotic but <strong>still mobile</strong> mitral valve leaflets. <strong>However, when the valve becomes heavily calcified and immobile, the opening snap disappears</strong>.</li>\r\n<li>AF leads to <strong>irregular rhythm</strong> and <strong>variable S1 intensity</strong>, making the auscultatory findings less consistent. A classic loud S1 and opening snap are typically <strong>not heard</strong> in persistent AF.</li>\r\n<li>AF abolishes <strong>presystolic accentuation</strong> of the diastolic murmur, but the <strong>opening snap remains</strong> as long as the valve is still mobile.</li>\r\n</ul>\r\n<p><strong>Clinical Signs of Mitral Stenosis:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025091012636ca3-467b-407b-a661-07b60c488895.png\">\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>This patient has an increased risk of stroke (Option A): </strong>True-mitral stenosis with AF significantly increases embolic (stroke) risk.</p>\r\n<p><strong>\"a\" wave is absent on JVP (Option B): </strong>True-in AF, there is loss of coordinated atrial contraction, so no \"a\" wave.</p>\r\n<p><strong>This patient has features of right heart failure (Option C): </strong>True-elevated JVP and tender hepatomegaly suggest right-sided congestion.</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Synovial inflammation with pannus formation</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Cartilage degeneration with osteophyte formation</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Subepidermal blister with IgA deposits</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Tophus with monosodium urate crystals</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with morning stiffness and tests positive for anti-CCP antibodies. Which of the following histological features is most characteristic of the underlying disease?</span></p>",
      "unique_key": "DT1325347",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Morning stiffness with positive anti-cyclic citrullinated peptide (anti-CCP) antibodies is diagnostic of rheumatoid arthritis. The hallmark histopathologic finding in rheumatoid arthritis is synovial inflammation leading to the formation of a pannus-an invasive granulation tissue-over the articular cartilage. Over time, this pannus causes destruction of cartilage and bone, resulting in joint deformity.</p>\r\n<p><strong>Rheumatoid arthritis typically presents with symmetrical small joint involvement, prolonged morning stiffness, and characteristic hand deformities.</strong></p>\r\n<ul>\r\n<li>Chronic synovitis leads to ligament laxity and joint deformities.</li>\r\n<li>Ulnar deviation at the MCP joints is a hallmark sign.</li>\r\n<li><strong>Rheumatoid arthritis typically affects the MCP and PIP joints but spares the DIP joints, making DIP sparing a distinguishing feature.</strong></li>\r\n<li>The disease commonly affects women between 30-50 years.</li>\r\n<li>Multiple joint involvement</li>\r\n<li>Early morning increase in symptoms</li>\r\n<li>X-ray showing the classical ulnar drift of the fingers at the MCP joint</li>\r\n<li>X-ray findings in RA\r\n<ul>\r\n<li>Periarticular osteopenia (earliest change)</li>\r\n<li>Uniform joint space narrowing</li>\r\n<li>Erosions of the articular surface</li>\r\n<li>Subchondral cysts</li>\r\n<li>No osteophytes</li>\r\n<li>Deformities</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>Cartilage degeneration with osteophyte formation (Option B): </strong>Seen in osteoarthritis, not rheumatoid arthritis.</p>\r\n<p><strong>Subepidermal blister with IgA deposits (Option C): </strong>Characteristic of dermatitis herpetiformis.</p>\r\n<p><strong>Tophus with monosodium urate crystals (Option D):</strong> Seen in gout.</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Administration of intravenous rTPA</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid Doppler ultrasound</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Transesophageal echo</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">IV low molecular weight heparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old patient with hypertension and atrial fibrillation presents with an acute-onset weakness of right side of body and aphasia, which began 2 hours ago. A non-contrast CT scan of the brain shows no evidence of haemorrhage. What is the next best step in management?</span></p>",
      "unique_key": "DT1325348",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325348,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In a patient presenting with acute stroke symptoms and risk factors such as atrial fibrillation, the immediate priority is to restore cerebral blood flow if within the therapeutic window (usually within 4.5 hours of symptom onset). Intravenous recombinant tissue plasminogen activator (rTPA) is the standard thrombolytic agent used for ischemic stroke management to dissolve the clot and reduce neurological damage.</p>\r\n<ul>\r\n<li>Ischemic stroke is one of the leading causes of morbidity and mortality. It is considered a clinical emergency, and timely diagnosis and treatment can improve the patient's outcome.</li>\r\n<li>When a stroke is suspected, emergent brain imaging is essential to confirm the diagnosis of ischemic stroke before thrombolytics can be administered.</li>\r\n<li>Noncontrast computed tomography (CT) scanning is the most commonly used form of neuroimaging to evaluate a patient suspected of having an acute stroke.</li>\r\n<li>This patient presents with <strong>acute ischemic stroke</strong> (right MCA territory) within 2 hours, confirmed by CT (no haemorrhage) and MRI (ischemic injury).</li>\r\n<li><strong>Alteplase</strong>, a tissue plasminogen activator, is indicated within 3-4.5 hours of symptom onset in eligible patients to lyse clots and restore cerebral blood flow. It binds fibrin in thrombi, converting plasminogen to plasmin for fibrinolysis.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Carotid Doppler ultrasound (Option B): </strong>Used later for evaluation of extracranial carotid stenosis as a source of embolism. Not part of <em>immediate</em> stroke management.</p>\r\n<p><strong>Transesophageal echo (Option C):</strong> May identify cardiac sources of emboli, but is not part of acute management.</p>\r\n<p><strong>IV low molecular weight heparin (Option D): </strong>Anticoagulation is important for stroke prevention but not the first step in the acute management of ischemic stroke in the thrombolysis window.</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Start antiretroviral therapy (ART) 2 weeks after initiating anti-tubercular therapy (ATT)</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ATT and ART simultaneously</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ART after completing the course of ATT</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ATT 2 weeks after initiating ART</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An HIV-positive patient presents with a 2-week history of fever, cough, and weight loss. He is diagnosed with tuberculosis. What is the most appropriate approach to management?</span></p>",
      "unique_key": "DT1325349",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325349,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In patients with HIV/AIDS and newly diagnosed tuberculosis, anti-tubercular therapy (ATT) should be started first. ART is then initiated 2 weeks later in those with low CD4 counts or severe disease (such as miliary tuberculosis). This delay helps reduce the risk of immune reconstitution inflammatory syndrome (IRIS), a potentially life-threatening complication, while ensuring both infections are appropriately managed.</p>\r\n<ul>\r\n<li>If a person is positive for <strong>both HIV and TB, Treatment for TB should be started first.</strong></li>\r\n<li>In a person positive with both HIV and TB, signs and symptoms of TB are less prominent due to <strong>decreased cellular immunity (due to decreased CD4 count )</strong></li>\r\n<li><strong>If ART is given 1st to this person, the cellular immunity will be increased, and there will be a flare-up of signs and symptoms of TB. This is known as Immune reconstitution inflammatory syndrome ( IRIS).</strong></li>\r\n<li><strong>Hence, ATT is given first to prevent this.</strong></li>\r\n<li>ATT is given for a minimum of 2 weeks, followed by ART.</li>\r\n<li>With rifampicin-containing regimen :\r\n<ul>\r\n<li>An additional dose of DTG 50mg should be taken after 12 hours on the same day, as rifampicin decreases the bioavailability of dolutegravir ( DTG)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>Start ATT and ART simultaneously (Option B): </strong>Starting both at once increases the risk of IRIS and can make management of drug interactions and side effects challenging.</p>\r\n<p><strong>Start ART after completing the course of ATT (Option C):</strong> Delaying ART until ATT is completed may result in immunological decline and increased mortality in people with low CD4 counts.</p>\r\n<p><strong>Start ATT 2 weeks after initiating ART</strong><strong> (Option D): I</strong>nitiating ART before ATT <strong>worsens TB due to IRIS </strong>and is<strong> not recommended.</strong></p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral distal symmetric polyneuropathy</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Autonomic neuropathy</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Mononeuropathy</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute motor axonal neuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man with a long-standing history of diabetes mellitus presents with numbness and tingling in both feet. On examination, deep tendon reflexes in the lower limbs are reduced. Which of the following is the most likely cause of his symptoms?</span></p>",
      "unique_key": "DT1325350",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325350,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The most common type of diabetic neuropathy is distal symmetric polyneuropathy. It primarily affects the sensory and motor nerves in a \"<strong>stocking and glove\" distribution,</strong> starting distally in the feet and progressing proximally.</p>\r\n<ul>\r\n<li>Diabetic distal Sensory and Sensorimotor Polyneuropathy (DSPN) is the most common form of diabetic neuropathy and manifests as sensory loss beginning in the toes that gradually progresses over time up the legs and into the fingers and arms.</li>\r\n<li><strong>Loss of ankle reflex is a hallmark sign. </strong></li>\r\n<li>Symptoms may include <strong>numbness, tingling, burning pain,</strong> and sometimes weakness.</li>\r\n<li>This neuropathy develops gradually and is the typical neuropathic pattern seen in long-standing diabetes.</li>\r\n<li>The most common cranial nerve involvement in Diabetes mellitus is the Oculomotor nerve, followed by the abducens and facial nerves.</li>\r\n</ul>\r\n<p><strong>Explanation of </strong><strong>Other </strong><strong>Options:</strong></p>\r\n<p><strong>Autonomic neuropathy (Option B):</strong></p>\r\n<ul>\r\n<li>Involves <strong>cardiovascular, gastrointestinal, and genitourinary systems</strong>.</li>\r\n<li>Symptoms: orthostatic hypotension, gastroparesis, erectile dysfunction, bladder dysfunction.</li>\r\n<li>Does <strong>not present with stocking-glove sensory loss</strong>, making it unlikely here.</li>\r\n</ul>\r\n<p><strong>Mononeuropathy (Option C):</strong></p>\r\n<ul>\r\n<li>Involves a <strong>single peripheral nerve</strong>, often due to ischemic or compressive etiology.</li>\r\n<li>Example: <strong>diabetic cranial mononeuropathy</strong> (commonly CN III).</li>\r\n<li>Presents with <strong>sudden focal weakness or sensory loss</strong>, not bilateral and symmetric as in this patient.</li>\r\n</ul>\r\n<p><strong>Acute Motor Axonal Neuropathy (AMAN) (Option D):</strong></p>\r\n<ul>\r\n<li>A <strong>variant of Guillain-Barre syndrome (GBS)</strong>.</li>\r\n<li>Seen in <strong>children/young adults</strong>, more common in <strong>China and Mexico</strong>, sometimes seasonal.</li>\r\n<li>Characterized by <strong>pure motor weakness</strong> without sensory loss.</li>\r\n<li>Associated with <strong>anti-GD1a antibodies</strong>.</li>\r\n<li>Typically post-infectious (e.g., <em>Campylobacter jejuni</em>) with <strong>rapid recovery</strong>, unlike gradual diabetic neuropathy.</li>\r\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">3% NaCl</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">0.9% NaCl</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">IV insulin</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Monitor potassium level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old female, a known case of insulin-dependent diabetes mellitus (IDDM), presents to the emergency department with altered sensorium. She has a history of missing her insulin doses for the past two days. On examination, her blood pressure is 80/60 mmHg and pulse rate is 103/min. Laboratory values reveal a serum sodium of 126 mEq/L, potassium 4.3 mEq/L, BUN 79 mg/dL, creatinine 2.2 mg/dL, and a random blood glucose level of 720 mg/dL. Which of the following is not a part of the initial management of this patient?</span></p>",
      "unique_key": "DT1325351",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325351,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>This patient is presenting with diabetic ketoacidosis (DKA), as suggested by hyperglycemia, hypotension, and features of dehydration.</li>\r\n<li>Initial management of DKA includes starting with isotonic saline (0.9% NaCl) for volume resuscitation, administration of IV insulin, and careful monitoring and correction of potassium levels.</li>\r\n<li>Hypertonic saline (3% NaCl) is not indicated unless there is severe, symptomatic hyponatremia with neurological signs, which is not typically present in DKA.</li>\r\n<li>The mild hyponatremia observed here is most often due to hyperglycemia-induced pseudohyponatremia and corrects with volume resuscitation and reduction of glucose.</li>\r\n</ul>\r\n<p><strong>The diagnostic criteria for Diabetic Ketoacidosis:</strong></p>\r\n<ul>\r\n<li>pH &lt; 7.3</li>\r\n<li>Serum bicarbonate &lt; 15 mEq/L</li>\r\n<li>Ketonuria / Ketonemia (Serum beta-hydroxybutyrate&gt; 3 mmol/L)</li>\r\n<li>Blood glucose &gt; 250 mg/dl</li>\r\n</ul>\r\n<p><strong>Clinical symptoms and signs:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025091098327359-9d4e-4423-835e-7bf2fd9016d0.png\">\r\n<p><strong>Laboratory findings:</strong></p>\r\n<ul>\r\n<li>High serum blood glucose levels</li>\r\n<li>Presence of urine ketone bodies</li>\r\n<li>Raised serum osmolality</li>\r\n<li><strong>Pseudohyponatremia</strong> (due to raised blood glucose)</li>\r\n<li>High anion gap metabolic acidosis</li>\r\n<li><strong>Hyperamylasemia</strong></li>\r\n<li>Hyperkalemia</li>\r\n<li>Hyperphosphatemia</li>\r\n</ul>\r\n<p><strong>Management of diabetic ketoacidosis:</strong></p>\r\n<ul>\r\n<li>Replace fluids\r\n<ul>\r\n<li><strong>Fluid Replacement </strong>is the cornerstone of management.</li>\r\n<li>2-3 L of 0.9% saline or lactated Ringer's over the first 1-3 h <strong>(Option B ruled out)</strong></li>\r\n<li>Fluid of choice: Normal saline</li>\r\n</ul>\r\n</li>\r\n<li>Administer<strong> short-acting regular insulin</strong>:\r\n<ul>\r\n<li>Intravenous insulin 0.1 units/kg per hour is administered by continuous IV infusion<strong>(Option C ruled out)</strong></li>\r\n<li>Dose increased two- to threefold if no response by 2-4 h.</li>\r\n<li>If the initial serum potassium is &lt;3.3 mmol/L (3.3 meq/L), do not administer insulin until the potassium is corrected.</li>\r\n<li>When serum glucose reaches 200 mg/dL, reduce regular insulin infusion to 0.02 to 0.05 units/kg/hour IV, or give rapid-acting Insulin at 0.1 units/kg SC every two hours.</li>\r\n<li>Keep serum glucose between 150 and 200 mg/dL until resolution of DKA.</li>\r\n</ul>\r\n</li>\r\n<li>Check electrolytes, BUN, venous pH, creatinine, and glucose every two to four hours until stable. <strong>(Option D ruled out)</strong></li>\r\n<li>After resolution of DKA and when the patient can eat, initiate SC multidose (basal-bolus) insulin regimen</li>\r\n<li>Continue IV insulin infusion for two to four hours after SC insulin is begun to ensure adequate plasma insulin levels.</li>\r\n<li>In insulin naive patients, start at 0.5 to 0.8 units/kg body weight per day, and adjust insulin.n as needed.</li>\r\n<li>Look for precipitating cause(s)</li>\r\n</ul>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventilation-perfusion (V/Q) scan</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest X-ray</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Pulmonary Angiography (CTPA)</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">D-dimer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female presents with respiratory distress and hemoptysis on day 7 after knee replacement surgery. Her respiratory rate is 28/min, and pulse is 120/min. What is the most appropriate investigation?</span></p>",
      "unique_key": "DT1325352",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325352,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In a post-operative patient with acute onset of respiratory distress, tachycardia, and hemoptysis, pulmonary embolism is highly suspected. CT Pulmonary Angiography (CTPA) is the gold standard for the diagnosis of pulmonary embolism in hemodynamically stable patients.</p>\r\n<p><strong>Pulmonary Embolism (PE)</strong></p>\r\n<ul>\r\n<li>Pulmonary embolism occurs when a thrombus (most often from the deep veins of the legs or pelvis) travels to the pulmonary arteries, causing obstruction of pulmonary blood flow, ventilation-perfusion (V/Q) mismatch, and impaired gas exchange.</li>\r\n<li>It is a <strong>life-threatening emergency</strong></li>\r\n</ul>\r\n<p><strong>Causes &amp; Risk Factors (Virchow's Triad)</strong></p>\r\n<ul>\r\n<li><strong>Stasis of blood flow</strong>: Prolonged immobilization, post-surgery, long travel, heart failure</li>\r\n<li><strong>Endothelial injury</strong>: Trauma, surgery, indwelling catheters</li>\r\n<li><strong>Hypercoagulability</strong>: Malignancy, pregnancy, oral contraceptives, inherited thrombophilia</li>\r\n</ul>\r\n<p><strong>Clinical Features</strong></p>\r\n<p><strong>Classic Triad</strong> (though not always present):</p>\r\n<ol>\r\n<li>Dyspnea (sudden-onset shortness of breath)</li>\r\n<li>Chest pain (pleuritic, worse on inspiration)</li>\r\n<li>Hemoptysis</li>\r\n</ol>\r\n<p><strong>Other features include</strong>:</p>\r\n<ul>\r\n<li>Tachypnea (most common sign)</li>\r\n<li>Tachycardia</li>\r\n<li>Hypoxemia (&darr; SpO<sub>2</sub>)</li>\r\n<li>Cough, syncope, anxiety, diaphoresis</li>\r\n<li>Signs of DVT (swollen, tender calf)</li>\r\n</ul>\r\n<p><strong>Severe/massive PE</strong>: Hypotension, shock, right heart failure, sudden death</p>\r\n<p><strong>Pathognomonic Sign</strong></p>\r\n<ul>\r\n<li><strong>Hampton's Hump</strong>: Wedge-shaped pleural-based opacity on CXR</li>\r\n<li><strong>Westermark's Sign</strong>: Regional oligemia (focal decrease in vascular markings)</li>\r\n</ul>\r\n<p><strong>Investigations</strong></p>\r\n<ul>\r\n<li><strong>ABG</strong>: Hypoxemia, respiratory alkalosis (low PaCO<sub>2</sub>)</li>\r\n<li><strong>D-dimer</strong>: Elevated (sensitive, not specific) <strong>(Option D ruled out)</strong></li>\r\n<li><strong>Chest X-ray</strong>: Often normal; may show Hampton's hump / Westermark's sign<strong> (Option B ruled out)</strong></li>\r\n<li><strong>CT Pulmonary Angiography (CTPA)</strong>: Gold standard imaging test</li>\r\n<li><strong>V/Q Scan</strong>: Used when CTPA contraindicated <strong>(Option A ruled out)</strong></li>\r\n<li><strong>Doppler Ultrasound leg veins</strong>: To detect the source of DVT</li>\r\n<li><strong>ECG</strong>: Sinus tachycardia is the most common; may show S1Q3T3 pattern (acute cor pulmonale)</li>\r\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Brainstem evoked potential</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Electroencephalogram (EEG)</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI brain</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">CSF analysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient in altered sensorium is found to have a serum sodium of 95 mEq/L. She was treated with 3% hypertonic saline, and after 24 hours, her sodium level increased to 111 mEq/L. After sodium correction, her neurological status has deteriorated. What is the next best step in management?</span></p>",
      "unique_key": "DT1325353",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325353,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Overly rapid correction of hyponatremia, particularly with hypertonic (3%) saline, can result in central pontine myelinolysis (osmotic demyelination syndrome)</strong>, presenting with neurological deterioration after correction <strong>(new deficits, altered sensorium, dysarthria, quadriparesis, pseudobulbar palsy). </strong>The next<strong> best diagnostic step is MRI brain</strong>, which can detect characteristic <strong>demyelinating lesions (especially in the pons)</strong> and confirm the diagnosis.</p>\n<ul>\n<li>Overly rapid correction of hyponatremia (&gt;8-10 mM in 24 h or 18 mM in 48 h) is also associated with a disruption in the integrity of the blood-brain barrier, allowing the entry of immune mediators that may contribute to demyelination.</li>\n<li>In severe hyponatremia, sodium should be corrected gradually, i.e., <strong>&le;8 mmol/L in 24 hours and &le;15 mmol/L in 48 hours.</strong></li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250922ddfb22ae-f831-4c10-bbf7-cf04e862b0a9.png\"><p><strong>Extrapontine Myelinosis:</strong></p>\n<ul>\n<li>Extrapontine myelinolysis (EPM) is a form of osmotic demyelination syndrome (ODS) that occurs outside the pons. It is often associated with the rapid correction of chronic hyponatremia.</li>\n<li>Other regions of the brain can also be involved in ODS, most commonly in association with lesions of the pons but occasionally in isolation.</li>\n<li>In order of frequency, the lesions of extrapontine myelinolysis can occur in the cerebellum, lateral geniculate body, thalamus, putamen, and cerebral cortex or subcortex. <strong>(Other options ruled out)</strong></li>\n<li>Clinical presentation of ODS can, therefore, vary as a function of the extent and localisation of extrapontine myelinolysis, with the reported development of ataxia, mutism, Parkinsonism, dystonia, and catatonia.</li>\n<li>Relowering of plasma Na+ concentration after overly rapid correction can prevent or attenuate ODS.</li>\n</ul>\n<p><strong>Central Pontine Myelinolysis</strong></p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202509221a55ae45-2f3c-4afb-b4eb-0782331e7477.png\"><p><strong>Explanation of Incorrect Options:</strong></p>\n<p><strong>Brainstem evoked potential (Option A):</strong> Not used for diagnosis of osmotic demyelination, but may be used for brainstem function in other contexts.</p>\n<p><strong>Electroencephalogram (EEG) (Option B): </strong>Detects electrical activity, useful for seizures or encephalopathy but not for demyelinating lesions.<br /> <strong>CSF analysis (Option D): </strong>CSF analysis is normal in ODS and is useful only for infections or inflammatory causes.</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphate binders only</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral calcium supplements</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium supplements with phosphate binders</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral calcium with vitamin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old child with chronic kidney disease is admitted for evaluation of bone pain and growth retardation. Laboratory investigations reveal: serum calcium 7.2 mg/dL, serum phosphate 6.3 mg/dL, alkaline phosphatase 370 U/L, and elevated parathyroid hormone levels. X-ray of the long bones shows metaphyseal dysplasia. Which of the following is the most appropriate treatment for this patient?</span></p>",
      "unique_key": "DT1325354",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>This patient is experiencing <strong>renal osteodystroph</strong>y <strong>(secondary hyperparathyroidism due to chronic kidney disease). </strong>The typical abnormalities include hypocalcemia, hyperphosphatemia, elevated PTH, and high ALP.</p>\n<p>The best initial treatment focuses on <strong>correcting hypocalcemia and reducing hyperphosphatemia. </strong>This is achieved by providing<strong> calcium supplementation and using phosphate binders </strong>to lower serum phosphate levels, which will help reduce PTH secretion and improve bone health.</p>\n\n\n\n\n\n<ul>\n<li><strong>Renal osteodystrophy</strong> is a collective term for skeletal abnormalities seen in chronic kidney disease (CKD). It includes:\n<ul>\n<li>Secondary hyperparathyroidism: Increased PTH leads to high bone turnover with subperiosteal resorption</li>\n<li>Osteomalacia: Due to defective vitamin D activation</li>\n<li>Adynamic bone disease: Low bone turnover due to PTH suppression (often from overtreatment)</li>\n</ul>\n</li>\n<li>Key features:\n<ul>\n<li>Bone pain</li>\n<li>Pathological fractures</li>\n<li>Growth retardation in children</li>\n<li>Radiological signs like rugger jersey spine and looser zones</li>\n<li>Biochemistry shows hypocalcemia, hyperphosphatemia, elevated ALP, and elevated PTH</li>\n</ul>\n</li>\n<li>Treatment includes phosphate binders, vitamin D analogs, and management of secondary hyperparathyroidism.</li>\n</ul>\n<p><strong>Explanation of Incorrect Options:</strong></p>\n<p><strong>Phosphate binders only (Option A): </strong>Phosphate binders lower phosphate but do not correct hypocalcemia, which is equally important in preventing further secondary hyperparathyroidism.</p>\n<p><strong>Oral calcium supplements (Option B): </strong>Calcium alone will not control phosphate retention, so PTH stimulation will persist.</p>\n<p><strong>Oral calcium with vitamin D (Option D): </strong>Vitamin D analogs are useful in CKD-related bone disease but <strong>phosphate binders are essential</strong> when hyperphosphatemia is present. Using calcium + phosphate binders directly addresses both derangements.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Emergency cardioversion</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Control ventricular rate</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Echocardiography to look for left atrial clot</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Start low molecular weight heparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old male presents to the emergency department with dyspnea and palpitations for the past 4 hours. ECG is suggestive of atrial fibrillation. He is hemodynamically stable. What is the next best step in management?</span></p>",
      "unique_key": "DT1325355",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>In a patient with <strong>hemodynamically stable atrial fibrillation</strong> presenting within 48 hours, the immediate priority is <strong>to control the ventricular rate</strong>. Rate control improves symptoms and hemodynamics while minimizing the risk of rapid conduction to the ventricles. Cardioversion may be considered after adequate anticoagulation, but it is not the initial step if the patient is stable and the onset is less than 48 hours.</p>\r\n<p><strong>Management of atrial fibrillation:</strong></p>\r\n<p><strong>Initial Management (Ventricular Rate Control)</strong></p>\r\n<ul>\r\n<li><strong>Goal:</strong> Control ventricular rate to prevent tachycardia-induced cardiomyopathy and improve symptoms.</li>\r\n<li><strong>First-line agents:</strong>\r\n<ul>\r\n<li><strong>Beta-blockers</strong> (e.g., metoprolol, bisoprolol, esmolol IV in acute setting)</li>\r\n<li><strong>Non-dihydropyridine calcium channel blockers</strong> (diltiazem, verapamil) - avoid in HFrEF</li>\r\n</ul>\r\n</li>\r\n<li><strong>Alternative/Add-on:</strong>\r\n<ul>\r\n<li><strong>Digoxin</strong> (esp. in sedentary or heart failure patients)</li>\r\n<li><strong>Amiodarone</strong> (when other agents are ineffective or contraindicated; also helps rhythm control)</li>\r\n</ul>\r\n</li>\r\n<li><strong>Target HR:</strong>\r\n<ul>\r\n<li><strong>Lenient control:</strong> &lt;110/min (if asymptomatic, normal LV function)</li>\r\n<li><strong>Strict control:</strong> &lt;80/min (if symptomatic or LV dysfunction</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202509108d3d21ce-a1cf-4bff-824f-883b89bb3da6.png\">\r\n<p><strong>Management of atrial fibrillation (CHA<sub>2</sub>DS<sub>2</sub>-VASc score-based):</strong></p>\r\n<ul>\r\n<li><strong>0-1 (Low risk):</strong> Cardioversion within 48 hrs may be done without anticoagulation.</li>\r\n<li><strong>&gt;/=2 or High-risk:</strong> Anticoagulation before and after cardioversion (duration of cardioversion must be considered).\r\n<ul>\r\n<li>Prefer <strong>NOACs</strong> (apixaban, dabigatran, rivaroxaban, edoxaban) over warfarin.</li>\r\n<li>Use <strong>warfarin (INR 2-3)</strong> in patients with <strong>mechanical valves or moderate/severe mitral stenosis</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Unknown/ AF&gt;48hrs:</strong> Anticoagulation for &gt;/=3 weeks before and 4 weeks after cardioversion, or rule out thrombus via TEE/CT.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025091044e49490-9d2a-4a82-a0ee-aea214f50c9b.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Emergency cardioversion</strong> <strong>(Option A):</strong> Reserved for <strong>hemodynamically unstable patients</strong> (shock, hypotension, pulmonary edema, ischemia). In stable AF &lt;48 hours, cardioversion may be considered, but only after ensuring anticoagulation status.</p>\r\n<p><strong>Echocardiography to look for left atrial clot</strong> <strong>(Option C):</strong> Indicated if AF &gt;48 hours or unknown duration before cardioversion, but not the first step in acute stable presentation.</p>\r\n<p><strong>Start low molecular weight heparin</strong> <strong>(Option D):</strong> Anticoagulation is essential for stroke prevention, especially in patients with high CHA<sub>2</sub>DS<sub>2</sub>-VASc scores, but it is <strong>not the immediate step</strong>. Initial management is rate control.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}